Copyright Reports & Markets. All rights reserved.

Global Blood Product Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Blood Product Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Albumin
      • 1.4.3 Immune Globulin
      • 1.4.4 Coagulation Factor
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Blood Product Market Share by Application (2014-2025)
      • 1.5.2 Immunity
      • 1.5.3 Therapy
      • 1.5.4 Surgery
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Blood Product Market Size
    • 2.2 Blood Product Growth Trends by Regions
      • 2.2.1 Blood Product Market Size by Regions (2014-2025)
      • 2.2.2 Blood Product Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Blood Product Market Size by Manufacturers
      • 3.1.1 Global Blood Product Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Blood Product Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Blood Product Market Concentration Ratio (CR5 and HHI)
    • 3.2 Blood Product Key Players Head office and Area Served
    • 3.3 Key Players Blood Product Product/Solution/Service
    • 3.4 Date of Enter into Blood Product Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Blood Product Market Size by Type (2014-2019)
    • 4.2 Global Blood Product Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Blood Product Market Size (2014-2019)
    • 5.2 Blood Product Key Players in United States
    • 5.3 United States Blood Product Market Size by Type
    • 5.4 United States Blood Product Market Size by Application

    6 Europe

    • 6.1 Europe Blood Product Market Size (2014-2019)
    • 6.2 Blood Product Key Players in Europe
    • 6.3 Europe Blood Product Market Size by Type
    • 6.4 Europe Blood Product Market Size by Application

    7 China

    • 7.1 China Blood Product Market Size (2014-2019)
    • 7.2 Blood Product Key Players in China
    • 7.3 China Blood Product Market Size by Type
    • 7.4 China Blood Product Market Size by Application

    8 Japan

    • 8.1 Japan Blood Product Market Size (2014-2019)
    • 8.2 Blood Product Key Players in Japan
    • 8.3 Japan Blood Product Market Size by Type
    • 8.4 Japan Blood Product Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Blood Product Market Size (2014-2019)
    • 9.2 Blood Product Key Players in Southeast Asia
    • 9.3 Southeast Asia Blood Product Market Size by Type
    • 9.4 Southeast Asia Blood Product Market Size by Application

    10 India

    • 10.1 India Blood Product Market Size (2014-2019)
    • 10.2 Blood Product Key Players in India
    • 10.3 India Blood Product Market Size by Type
    • 10.4 India Blood Product Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Blood Product Market Size (2014-2019)
    • 11.2 Blood Product Key Players in Central & South America
    • 11.3 Central & South America Blood Product Market Size by Type
    • 11.4 Central & South America Blood Product Market Size by Application

    12 International Players Profiles

    • 12.1 Baxter
      • 12.1.1 Baxter Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Blood Product Introduction
      • 12.1.4 Baxter Revenue in Blood Product Business (2014-2019)
      • 12.1.5 Baxter Recent Development
    • 12.2 CSL
      • 12.2.1 CSL Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Blood Product Introduction
      • 12.2.4 CSL Revenue in Blood Product Business (2014-2019)
      • 12.2.5 CSL Recent Development
    • 12.3 Grifols
      • 12.3.1 Grifols Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Blood Product Introduction
      • 12.3.4 Grifols Revenue in Blood Product Business (2014-2019)
      • 12.3.5 Grifols Recent Development
    • 12.4 Octapharma
      • 12.4.1 Octapharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Blood Product Introduction
      • 12.4.4 Octapharma Revenue in Blood Product Business (2014-2019)
      • 12.4.5 Octapharma Recent Development
    • 12.5 BPL
      • 12.5.1 BPL Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Blood Product Introduction
      • 12.5.4 BPL Revenue in Blood Product Business (2014-2019)
      • 12.5.5 BPL Recent Development
    • 12.6 Kedrion
      • 12.6.1 Kedrion Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Blood Product Introduction
      • 12.6.4 Kedrion Revenue in Blood Product Business (2014-2019)
      • 12.6.5 Kedrion Recent Development
    • 12.7 Mitsubishi Tanabe
      • 12.7.1 Mitsubishi Tanabe Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Blood Product Introduction
      • 12.7.4 Mitsubishi Tanabe Revenue in Blood Product Business (2014-2019)
      • 12.7.5 Mitsubishi Tanabe Recent Development
    • 12.8 CBOP
      • 12.8.1 CBOP Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Blood Product Introduction
      • 12.8.4 CBOP Revenue in Blood Product Business (2014-2019)
      • 12.8.5 CBOP Recent Development
    • 12.9 RAAS
      • 12.9.1 RAAS Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Blood Product Introduction
      • 12.9.4 RAAS Revenue in Blood Product Business (2014-2019)
      • 12.9.5 RAAS Recent Development
    • 12.10 Hualan Bio
      • 12.10.1 Hualan Bio Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Blood Product Introduction
      • 12.10.4 Hualan Bio Revenue in Blood Product Business (2014-2019)
      • 12.10.5 Hualan Bio Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
      North America is the largest supplier of Blood Product, with production revenue market share about 60%, and the sales market share is 40% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
      Europe, following North America, takes production revenue market share of 20% and the sales market share over 20%. China is an important market of Blood Product in Asia, accounting for 9% production revenue market share and 14% sales revenue market share of global market.
      Japan has equal production revenue market share and sales revenue market share nearly. The local production can meet most local demand, and there is a small amount of imports.
      In 2018, the global Blood Product market size was 26100 million US$ and it is expected to reach 55000 million US$ by the end of 2025, with a CAGR of 9.8% during 2019-2025.

      This report focuses on the global Blood Product status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Product development in United States, Europe and China.

      The key players covered in this study
      Baxter
      CSL
      Grifols
      Octapharma
      BPL
      Kedrion
      Mitsubishi Tanabe
      CBOP
      RAAS
      Hualan Bio

      Market segment by Type, the product can be split into
      Albumin
      Immune Globulin
      Coagulation Factor
      Others

      Market segment by Application, split into
      Immunity
      Therapy
      Surgery
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Blood Product status, future forecast, growth opportunity, key market and key players.
      To present the Blood Product development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Blood Product are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now